dcemancipation.org

PRIEST’S LOVER

0 Comments | Sunday Mirror, Nov 22, 2009 | by VICTORIA McMAHON

THE pretty student nurse smiling out from the photograph is Elaine Curran – a separated mum-of-two who is currently at a Donegal hideaway with her priest lover, Father Sean McKenna.

The couple have been lying low since last weekend when the Derry priest revealed he was leaving the priesthood after falling in love with Elaine.

But in another twist to the love story, we can reveal it was Father McKenna who officiated at her wedding to Liam Curran, at St Columba’s Church in August 1992.

Our snapshot shows the Elaine just three months after her wedding enjoying a student nurses’ formal at the Everglades Hotel in Derry.

Health Centre nurse Elaine, who has children aged six and 13, split with cash and carry worker Liam, also 38, three years ago.

Although Father McKenna and the Derry mum have known each other since she was a child at the city’s Nazareth House Orphanage, it was while both where helping out at Creggan Community Centre that they became close.

Mr Curran has refused to comment on his ex’s new relationship, but his mother said: “Fr Sean McKenna has known Elaine since her time in Nazareth House Orphanage.

“Three years ago Elaine and Liam broke up. The family is very upset about all of this and we are having a very hard time at the minute.”

Last Saturday and Sunday Fr McKenna stunned his Ballymagroarty congregations at Holy Family parish by telling them of his decision to quit the Catholic Church for a “loving” and “beautiful life- giving relationship”.

He broke his silence on Friday in the wake of rumours speculating that Elaine is pregnant, slamming them as “completely untrue” and having caused “great distress”.

He said: “It is for this reason that I now find it a painful necessity to state the following points.

“Elaine and I have been friends for many years. However, our relationship began a long time after the break-up of her marriage.

“At no time did I counsel her. She is not pregnant
low carb diet tips

European SystemC User Group Meeting to be Held Dec. 1; Co-located with IP-ESC 2009 in Grenoble

Business Wire, Nov 23, 2009

Technical User Presentations Explore Virtual Platforms, Power
Analysis, SoC Modeling and More

GRENOBLE, France — Open SystemC Initiative:WHO: The Open SystemC
Initiative (OSCI), an independent, non-profit organization dedicated to
supporting and advancing SystemC as an industry-standard language for
electronic system-level (ESL) design, announced the European SystemC
User Group (ESCUG) will host its twentieth meeting Dec. 1, 2009 in
Grenoble, France. For the first time, the meeting will be co-located
with IP-ESC 2009, a technical conference focused on intellectual
property (IP) based system-on-chip (SoC) design. Event
registration as well as a full
agenda for ESCUG is available at www.systemc.org.

WHAT/WHEN/WHERE:

ESCUG 20 MeetingTuesday, December 1st, 2009, 15:30 – 18:30World
Trade Center, Grenoble, FranceRoom MakaluRegistration and
agenda: http://www.systemc.org/news/events/Co-located
with the IP-ESC Conference 2009: http://www.design-reuse.com/ipesc09/

[Table Omitted]

WHY: SystemC continues to grow in importance for architectural
exploration, performance analysis, building virtual platforms for
software development, and functional verification. User meetings
strengthen OSCIs mission and its dedication to providing mechanisms
that allow collaboration and information exchange among members of the
global ESL community.

SPONSORED BY: ARM, Cadence, CoWare, Doulos, Forte, Mentor
Graphics, Synopsys, Virtutech, XtremeEDA

About SystemC and OSCI

The Open SystemC Initiative (OSCI) is an independent, not-for-profit
association composed of a broad range of organizations dedicated to
supporting and advancing SystemC as an open industry standard for
system-level modeling, design and verification. SystemC is a language
built in C that spans from concept to implementation in hardware and
software
bass headphones

Lots of ways to give, receive this Thanksgiving

0 Comments | Oakland Tribune, Nov 21, 2009 | by Matthew Artz

When Phyllis Swainston got two turkeys for the price of one, she drove her spare bird to the Salvation Army’s Newark office.

But her good deed didn’t make her feel so great Thursday when she found out the charity still needed a lot more food.

“It broke my heart,” said the Union City resident, whose husband lost his insurance job earlier this year, not long after turning 60.

So Swainston headed to the nearest supermarket, where $40 bought her three turkeys, 10 cans of cranberry sauce, four boxes of stuffing, four packages of instant mashed potatoes and several cans of green beans to help feed needy families.

Others can do the same by dropping off food on weekdays between 9 a.m. and noon and 1 and 4 p.m. at the Salvation Army, 36700 Newark Blvd. Today, workers at the NUMMI auto plant, in Fremont, will drop off more than 1,000 pounds of nonperishable food and make care packages for the needy.

There are many other ways to give and lots of help to get in southern Alameda County this Thanksgiving season, whether you’re into cranberries or curry.

For a list of Alameda County food banks, food drives, free meals and volunteer opportunities, dial 211.

The week’s festivities begin with the Tri-City Interfaith Council’s 48th annual Tri-City Thanksgiving Service
arizona auto insurance quotes

HomeRoom

0 Comments | Oakland Tribune, Nov 21, 2009 | by Linh Tat

Fremont

American High play: Students will perform Paul Rudnick’s comedy, “I Hate Hamlet,” one last time tonight, in the school’s theater.

The play follows Andrew, an actor in a hit television show who is pegged to play Shakespeare’s “Hamlet” in New York. He’s reluctant, but the ghost of his agent’s former lover pushes him to take the part. More hilarity ensues as the play progresses.

The show, rated PG-13 for language and suggestive humor, will start at 7 p.m. American High School is at 36300 Fremont Blvd.

Tickets are $8 for students and $10 for general admission and may be purchased beginning 45 minutes before showtime.

Irvington High play: J.R.R. Tolkien’s “The Hobbit,” adapted by Patricia Gray, will be performed at 7:30 today and 2 p.m. Sunday in Irvington High’s Valhalla Theatre, 41800 Blacow Road.

Tickets are $10 for general admission and $8 for those with student body cards, children under 12 and seniors.

Student scholar: Irvington High School senior Radhika Mitra has won a $5,000 Dreamers Challenge scholarship for her efforts to support artists and help them market their products globally through her nonprofit, Renaissance Now.

She and a second winner from Southern California will be recognized by the state’s first lady, Maria Shriver, at the California Hall of Fame induction ceremony Dec. 1.

The scholarship is sponsored by Comcast, in partnership with the California Department of Education and California State Fair and Exposition.

Blood drive: Mission San Jose High School students donated 87 pints of blood to the American Red Cross last week, surpassing organizers’ goal by seven pints.

The next blood drive will be held from 10 a.m
onkyo tx-sr507

Sigma Corporation Now Accepting Applications for Student Photography Scholarship

Market Wire, November, 2009

Sigma Corporation of America
( www.sigmaphoto.com ), a leading researcher, developer, manufacturer and
service provider of some of the world’s most impressive lines of lenses , cameras and flashes ,
is pleased to announce that it is now accepting applications for the
company’s first-ever scholarship contest.

The Sigma Corporation of
America Scholarship will award a cash gift of $5,000 and $1,000 in
Sigma products to one talented high school senior to advance his or her
education and goals toward obtaining a career in a photo-related field.
Students pursuing higher education in industries such as photography,
photojournalism, graphic arts and design, visual arts and art history are
eligible to apply.

Applicants are invited to visit the Sigma Corporation of America
Web site for more details and to complete an application form, which
includes a brief essay and the submission of up to five thematically-tied
photographs. The entire package will be judged based on creativity of
subject selection, overall technique and, most importantly, image quality.
Students are not required to use Sigma equipment to shoot the photographs
they submit.

“This scholarship illustrates Sigma’s five decades of technological
advancement and innovation in the industry, and our family-owned company’s
desire to empower and support up-and-coming photographers,” said Mark
Amir-Hamzeh, general manager of Sigma Corporation of America. “The
scholarship winner will be selected based on his or her ability to deliver
outstanding photographs with the superior caliber of image quality for
which the Sigma brand has become known.”

Applications will be accepted from Nov. 19, 2009 to Feb. 15, 2010 and can
be submitted via the Sigma Corporation of America Web site at
http://www.sigmaphoto.com/scholarship/ . Once the submission process closes,
the public will be invited to vote online for the top three students of
their choice from Feb. 16, 2010 to April 23, 2010. Sigma Corporation of
America executives will select a winner from the top three public
vote-getters and announce the scholarship recipient on May 3, 2010.

For information about the Sigma Corporation of America Scholarship,
eligibility, the application process, material submissions and a formal
list of contest rules, visit http://www.sigmaphoto.com/scholarship/ .

For information on Sigma Corporation of America and its lenses , cameras and flashes ,
visit www.sigmaphoto.com .

About Sigma Corporation of America

For more than 50 years, Sigma Corporation has been producing high-quality,
high-performance photographic technology at moderate prices. This
family-owned organization is the largest, independent SLR lens manufacturer
in the world, producing more than 40 lenses that are compatible with most
manufacturers, including Canon, Minolta, Sony, Nikon, Olympus and Pentax.
Sigma Corporation also produces digital SLR cameras and high-definition
digital compact cameras. The company is headquartered in Japan, with
offices strategically located throughout Europe and North America
nature photography

Monthly malware statistics from Kaspersky Lab: May

Database and Network Journal, June, 2009

The first Top Twenty is based on data collected by Kaspersky Lab’s version 2009 antivirus product. The ranking is made up of the malicious programs, adware and potentially unwanted programs most frequently detected on users’ computers.

There were no significant changes to the Top Twenty in May.

There are only two newcomers: Palevo.ddm, a P2P worm and Swizzor.a, a Trojan.

The former, in addition to spreading in various public peer-to-peer networks, infects removable media. This gives it an additional boost, helping it to spread even more widely.

The latter utilises some interesting and sophisticated code obfuscation tricks and methods for masking its presence on the system. Since hundreds of new variants of this malicious program are generated every day on cybercriminal servers, this Trojan has made it into both our Top Twenty rankings.

All malicious, advertising and potentially unwanted programs in the first Top Twenty can be grouped according to the main classes of threat, which we detect. In the past few months, the changes in the balance between these classes have not exceeded 5%.

A total of 42,520 unique malicious, advertising, and potentially unwanted programs were detected on users’ computers in May. This figure is almost exactly the same as last month’s. The second Top Twenty presents data on which malicious programs most commonly infected objects detected on users’ computers. Malicious programs capable of infecting files make up the majority of this ranking.

Contrary to the trend of the past several months, May saw more changes to the second ranking than the first.

The most interesting changes were: TrojanClicker.HTML.IFrame.aga, going straight in to third place, and the appearance, albeit at the bottom of the ranking, of Virus.Win32.Sality.ae.

IFrame.aga is one more version of the iframe that the now widespread Virus.Win32.Virut.ce uses to infect web pages. And Sality.ae is the latest version of the well-known Sality virus. The new variant replaces Sality.y after it dropped out of our ranking in January. As a result, there are three members of this family on our ranking again
spyzooka

Audio-Technica Noise-Cancelling Headphones Make An Ideal Holiday Gift

Business Wire, Nov 17, 2009

Noise-cancelling headphones are becoming the mary frances handbags headphones of choice for a
growing number of listeners, thanks to their ability to block out the
cacophony of an increasingly raucous world and let wearers enjoy their
favorite music, undisturbed by environmental noise. This holiday season, Audio-Technica
offers the perfect holiday gift for music lovers the new ATH-ANC7b
Quiet Point active noise-cancelling over-ear headphones
with 90% noise-cancellation. (SRP: $219.95).

Crystal Griffith, Consumer Marketing Manager of Audio-Technica noted,
The explosion of portable music players like the iPod, the
iPhone, and laptops means that more people are listening on headphones
than ever before. Headphones are becoming the primary means of listening
to music for many and people want to hear their music with the best
fidelity possible. By eliminating intrusive environmental sounds,
noise-cancelling headphones like the Audio-Technica ATH-ANC7b give
listeners maximum musical enjoyment.

Griffith continued, Noise-cancelling headphones provide a welcome
respite from the racket of jet engine noise, trains, crowded city
streets, lawnmowers and other noisy situations. They can also help
students study, by blocking distracting outside disturbances.

Headphones like the Audio-Technica ATH-ANC7b headphones use
sophisticated QuietPoint active noise-cancellation technology that
detects environmental noise via miniature microphones in each earpiece,
and applies a corresponding sound-cancelling signal to block 90% of
outside noise.

Winner of a CES Innovations 2010 award, the ATH-ANC7b delivers
exceptional sound quality, with impactful bass, a detailed midrange,
extended treble and accurate imaging. The ATH-ANC7b also works when the
noise-cancelling function is turned off, or without batteries, so
listeners are never without their music

Knology Announces Acquisition of the Assets of Private Cable Co., LLC for $7.5 Million Cash

Business Wire, Nov 17, 2009

WEST POINT, Ga. — Knology, Inc. (Nasdaq: KNOL) today announced that it has closed on the
acquisition of the assets of Private Cable Co., LLC (PCL Cable) for
$7.5 million in cash. PCL Cable, a provider of video, voice and data
services to residential and business customers in Athens and Decatur,
Alabama, generates approximately $5million in annualized revenue and
$1.5 million in annualized EBITDA, before considering potential
synergies. M. Todd Holt, Knologys President and Chief Financial
Officer, said, We are very excited to welcome the employees of PCL to
the Knology family. This transaction is a nice fit with Knology both
from an grow taller exercises operational and financial perspective

Boeing Selects Best Doctors to Help Employees Get the Right Care

Business Wire, Nov 17, 2009

Leading aerospace manufacturer expands Well Being program to include
expert medical consultation service

BOSTON — Best Doctors, Inc., a provider of employer-based health benefits that
help members get the right care, today announced that The Boeing
Company, the worlds leading aerospace company, has selected Best
Doctors benefit to include among its portfolio of Well Being resources.
Through Best Doctors, Boeing employees and their dependents now have
access to ear infection symptoms some of the nations most advanced medical expertise when they
are uncertain about their diagnosis or treatment options.

Best Doctors helps companies and organizations provide employees and
their treating physicians with information that will get them on the
right clinical path without spending time, energy and money pursuing
inappropriate treatment. Best Doctors serves as a trusted resource for
some of the toughest medical situations, such as: unclear diagnoses;
choosing a course of treatment; or, what questions patients should ask
of their physicians.

The Best Doctors benefit allows Boeing employees to have their medical
cases evaluated by nationally-recognized expert physicians who will
conduct a thorough analysis based on medical records, history and tests.
After the review, members receive a comprehensive, easy-to-understand
report summarizing the experts findings that can be then used by their
treating physicians.

If youre sick, youre entitled to be sure you are getting the right
care, said Evan Falchuk, president of Best Doctors

Interim Phase 2 Survival Data for PV-10 Will Be Presented by Professor John F. Thompson, MD, on November 21, 2009

Business Wire, Nov 17, colon cancer surgery 2009

Lead Investigator for Provectus PV-10 Trial Will Present At 3rd
World Meeting of Interdisciplinary Melanoma/Skin Cancer Centers in Berlin

Will Update Compassionate Use Program

KNOXVILLE, Tenn. — Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a development-stage
oncology and dermatology biopharmaceutical company, announced today that
Professor John F. Thompson, MD, Professor of Melanoma and Surgical
Oncology at the University of Sydney, Director of the Melanoma Institute
Australia, and Lead Investigator of the Phase 2 study of PV-10 for
Metastatic Melanoma, will be presenting data at the 3rd World
Meeting of Interdisciplinary Melanoma/Skin Cancer Centers on November
21, 2009 in Berlin, Germany.

In his presentation entitled PV-10 in the Local Treatment of Melanoma
Metastasis, Professor Thompson will be presenting overall survival data
for the Phase 1 and Phase 2 trials as well as an update on data from the
expanded access use of PV-10 in Australia and the United States
(Compassionate Use). Provectus expects to issue a press release to
update shareholders and the medical and scientific community regarding
the data early next week after the completion of the presentation.

Craig Dees, PhD, CEO of Provectus said, We are excited about Professor
Thompsons presentation, which will be the first time that interim
survival data for the Phase 2 trial will be presented. Further, his
discussion will provide the first look at the progress that has been
made with our expanded access program for PV-10, the means through which
certain qualified patients can receive PV-10 on a compassionate use
basis, in Australia and the United States. Both of these aspects of his
presentation are certain to be very enlightening on the topic of PV-10s
continued development.

About the 3rd World Meeting of
Interdisciplinary Melanoma/Skin Cancers

This meeting provides a unique opportunity for melanoma clinicians and
researchers, who are part of multidisciplinary melanoma/skin cancer
centers to interact, learn from one another, establish collaborations
and set an agenda for the further evolution of multidisciplinary
melanoma care and research. The conference will feature Plenary Session
and Symposia speakers who are recognized experts in melanoma treatment
and research.

About PV-10

PV-10 is a proprietary, injectable formulation of Rose Bengal, a
compound that has been in use for nearly thirty years by
ophthalmologists to assess damage to the eye. It has also been used as
an intravenous diagnostic to detect ailments of the liver. Rose Bengal
is a small molecule agent with an established safety history, a short
half-life in the bloodstream, and is excreted via the liver and kidneys.
Provectus has discovered a novel use for Rose Bengal based on the
observation that it is selectively toxic to cancer calls via a process
called chemoablation whereby cells undergo a form of cell death that
mimics both features of necrosis and apoptosis.

About Provectus Pharmaceuticals, Inc. (www.pvct.com)

Provectus Pharmaceuticals specializes in developing oncology and
dermatology therapies. Its lead oncology agent, PV-10, is designed to
selectively target and destroy cancer cells without harming surrounding
healthy tissue, significantly reducing systemic side effects. Its
oncology focus is on melanoma, breast cancer and metastatic liver
cancer. The Company has received orphan drug designation from the FDA
for its melanoma indication. Its lead dermatological drug, PH-10, also
targets abnormal or diseased cells, with the current focus on psoriasis
and atopic dermatitis. Provectus has recently completed enrollment in
three of its Phase 2 trials — PV-10 as a therapy for metastatic
melanoma, and PH-10 as a topical treatment for atopic dermatitis and for
psoriasis. It has also recently initiated a Phase 1 trial for PV-10 for
liver cancer. Information about these and the Company’s other clinical
trials can be found at the NIH registry, www.clinicaltrials.gov